Instituto de Investigación Biomédica de A Coruña (INIBIC)
Research center
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublications in collaboration with researchers from Institut d'Investigació Biomédica de Bellvitge (24)
2024
-
Correction to: Exploring the potential of Chat-GPT as a supportive tool for sialendoscopy clinical decision making and patient information support (European Archives of Oto-Rhino-Laryngology, (2024), 281, 4, (2081-2086), 10.1007/s00405-023-08104-8)
European Archives of Oto-Rhino-Laryngology
-
Exploring the potential of Chat-GPT as a supportive tool for sialendoscopy clinical decision making and patient information support
European Archives of Oto-Rhino-Laryngology, Vol. 281, Núm. 4, pp. 2081-2086
-
Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes
Nature Communications, Vol. 15, Núm. 1
-
Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study
Revista Espanola de Cardiologia
-
Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313
2023
-
Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (Nature Genetics, (2023), 55, 1, (89-99), 10.1038/s41588-022-01222-9)
Nature Genetics
-
Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era (Bone Marrow Transplantation, (2023), 58, 6, (673-679), 10.1038/s41409-023-01949-x)
Bone Marrow Transplantation
-
Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
Nature Genetics, Vol. 55, Núm. 1, pp. 89-99
-
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era
Bone Marrow Transplantation, Vol. 58, Núm. 6, pp. 673-679
-
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer
Lung Cancer, Vol. 178, pp. 116-122
-
iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy
Circulation Research, Vol. 133, Núm. 2, pp. 108-119
2022
-
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy
Journal for immunotherapy of cancer, Vol. 10, Núm. 9
2021
-
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)
PLoS ONE, Vol. 16, Núm. 9 September
-
The SEEN comprehensive clinical survey of adult obesity: Executive summary
Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 2, pp. 130-136
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252
2020
-
Mesenchymal stromal cells for articular cartilage repair: Preclinical studies
European Cells and Materials, Vol. 40, pp. 88-114
2019
-
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study
Breast Cancer Research and Treatment, Vol. 174, Núm. 3, pp. 693-701
-
Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors
Cancer Immunology, Immunotherapy, Vol. 68, Núm. 3, pp. 341-352